FARA

Fannavaran Riztrashe Ofogh (FARA): Pioneering Point-of-Care Diagnostic Innovations Our Story: Founded in 2022, Fanaavaran Riztracheh Ofogh (FARA) was established with a mission to revolutionize point-of-care diagnostic technologies. Leveraging advanced centrifugal microfluidic platforms and deep expertise in microsystems, we aim to provide innovative solutions that enhance healthcare and accelerate diagnostic processes. Our Products: Our focus is on developing and manufacturing point-of-care diagnostic kits with the highest accuracy and efficiency, including: - Advanced Immunoassay Technologies: Utilizing ELISA and chemiluminescence methods for rapid and precise detection. - Molecular Diagnostic Methods: Powered by cutting-edge PCR technology to deliver accurate and reliable results. Our Services: Beyond product development, we serve as your research partner and specialized consultant, supporting you from ideation to final production. With our expertise in designing and implementing microsystems, we offer smart products based on microfluidic platforms tailored to your needs. Our Vision: FARA envisions creating an innovation ecosystem in point-of-care diagnostics. By merging technology and expertise, we are committed to improving global healthcare and delivering sustainable value to our partners. Join us on LinkedIn to explore more about our work and collaborate in building a smarter future for healthcare.